Hey friends! We wanted to share some exciting news about a study happening at our center that involves the Primo Vision Evo Time-Lapse Embryo Monitoring System. This nifty system is designed for in vitro fertilization (IVF) treatments and allows clinicians to monitor embryo development without interrupting their growth. It’s like having a front-row seat to witness the miracle of life as it unfolds!
The study, conducted by Vitrolife, is all about comparing how well embryos grow when using the Primo Vision system versus traditional culture media. The goal is to see if this innovative method can improve embryo development, which could lead to better outcomes for those undergoing IVF.
Eligibility to Participate
If you’re currently on your fertility journey, you might be eligible to join this study. Here’s who can participate:
- Women under 40 using their own eggs for IVF
- Women under 55 using donor eggs
- No history of cancer
- Fresh or frozen sperm can be used
- At least six normally fertilized eggs (2PN)
For those interested in learning more or wanting to take part, it’s a good idea to chat with your IVF doctor or nurse about the details. They can provide all the info you need.
Just a heads up though, the Primo Vision Evo system is still investigational and hasn’t yet been approved for sale by the FDA in the U.S.
If you’re looking for more insights on fertility, check out this post on mindful pregnancy. It offers some great perspectives! Also, you might want to explore fertility supplements that can enhance your chances of conception, like those featured at Make a Mom. And don’t forget, if you’re thinking about fertility treatment, the March of Dimes has some excellent resources to guide you through the process.
Summary
In summary, the Primo Vision study is a fascinating opportunity for women undergoing IVF to explore a new method of embryo monitoring that might improve outcomes. If you’re eligible, consider discussing participation with your healthcare provider.